A Study to Determine the Efficacy and Safety of Fasinumab for the Treatment of Adults With Chronic Low Back Pain

NCT02620020 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

563

Enrollment

INDUSTRY

Sponsor class

Conditions

Low Back Pain

Interventions

DRUG: Fasinumab
DRUG: placebo

Sponsor

Regeneron Pharmaceuticals